Press Releases
Press Releases
RBCC Target’s Brain Injury Treatment Awareness Campaign Reaches Milestone
Rainbow BioSciences, LLC, the biotech subsidiary of Rainbow Coral Corp., today announced the collaboration of its latest target, Amarantus BioSciences, Inc., with Brewer Sports International to increase awareness about new medical therapies in development to effectively treat traumatic...
Press Releases
Biogen Idec to Present at the Deutsche Bank 37th Annual Healthcare Conference
Biogen Idec Inc. announced today that its presentation at the Deutsche Bank 37th Annual Healthcare Conference will be webcast live on Tuesday, May 8, 2012 at 10:00 a.m. ET. To access the live webcast, please visit...
Press Releases
Anacor Pharmaceuticals to Present at the Deutsche Bank Annual Health Care Conference
Anacor Pharmaceuticals announced today that David Perry, the company’s Chief Executive Officer, will provide a company overview at the Deutsche Bank Annual Health Care Conference on Monday May 7, 2012 at 4:10 p.m. ET in Boston, Massachusetts. ...
Press Releases
ClinStar to Present at Outsourcing in Clinical Trials Europe
ClinStar, LLC, an established clinical research organization providing clinical development services in the emerging markets of Russia and Eastern Europe to the biopharmaceutical industry, announced today that President and CEO David Passov will present at Outsourcing in Clinical...
Press Releases
Novasep strengthens its management team with the appointment of Jean-Claude Romain as corporate quality director and Alain Lamproye as director of Novasep Bioproduction sites...
Novasep, a leading supplier of purification and production solutions for the life sciences industry, announces two new managerial appointments. Jean-Claude Romain becomes the group's corporate quality director and a member of Novasep's executive committee, while Alain Lamproye joins Novasep...
Press Releases
Adocia reports positive phase II clinical results for the treatment of diabetic foot ulcer
Adocia, a biotechnology company specialized in the development of best-in-class medicines with already approved therapeutic proteins, announces today positive results from its Phase II clinical trial evaluating the safety and efficacy of BioChaperone(R) combined with PDGF-BB for the treatment...
Press Releases
Novasep’s outstanding results in scale-up and biomanufacturing of Apo-A1 acknowledged by Cerenis at BioProcess International Conference
Novasep, a leading provider of purification-based manufacturing solutions for lifescience molecules, announces today that Cerenis Therapeutics has been invited by BioProcess International to present its major project CER – 001 ApoA1 - HDL mimetic drug candidate, and describe...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read